• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • View form
  • Code
  • History
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

Citation:Non-small Cell Lung Cancer Collaborative Group 1995

From Cancer Guidelines Wiki
Jump to:navigation, search

Citation


Non-small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311(7010):899-909 Available from: http://www.ncbi.nlm.nih.gov/pubmed/7580546.



Critical appraisals

  • Assign a critical appraisal


Compare quality appraisals for each clinical question

Cited by

  1. Emma.dickins/Sandbox
  2. Emma.dickins/Sandbox 2
  3. What is the clinical benefit of adjuvant chemotherapy for patients with stage III operable NSCLC?
  4. What is the optimal first-line chemotherapy regimen in patients with stage IV inoperable NSCLC?
  5. What is the optimal systemic therapy for stage IV inoperable NSCLC?
  6. What is the optimal systemic therapy for stage IV inoperable NSCLC?/Historical evolution of systemic drug treatment for stage IV NSCLC
  7. What is the recommended treatment approach for the definitive management of patients with good performance status and inoperable stage III disease?
  8. What is the role of chemotherapy after surgery in the treatment of operable stage II NSCLC?
  9. What is the role of chemotherapy before surgery in the treatment of operable stage II NSCLC?
Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Citation:Non-small_Cell_Lung_Cancer_Collaborative_Group_1995&oldid=20248"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.